“Minneapolis/St. Paul is a vibrant medical device market, which is IMARC’S main market focus,” John Lehmann, Director of Business Development, IMARC, told Outsourcing-Pharma.com, adding that the company has key accounts in the market.
“IMARC is focused on the medical device market and has experienced tremendous growth with both mid-size and large companies who are seeking outside CRO support,” added Lehmann.
The CRO works in a variety of therapeutic areas, but according to Lehmann, most of the company’s growth is coming from the cardiovascular (interventional, peripheral and vascular), in-vitro diagnostic, wound care, and orthopedic markets.
Lehmann added that the company is focused on continued growth, and the expansion into the Minneapolis market is part of that plan.
“We also plan on expanding business opportunities with our existing accounts and adding new clients to our roster,” he said.
IMARC recently also expanded its services offering to include data safety monitoring boards and clinical events committees, expanded its training offerings, and has grown its staff to meet the demand.